[go: up one dir, main page]

AU1669600A - New cancer treatments - Google Patents

New cancer treatments

Info

Publication number
AU1669600A
AU1669600A AU16696/00A AU1669600A AU1669600A AU 1669600 A AU1669600 A AU 1669600A AU 16696/00 A AU16696/00 A AU 16696/00A AU 1669600 A AU1669600 A AU 1669600A AU 1669600 A AU1669600 A AU 1669600A
Authority
AU
Australia
Prior art keywords
cancer treatments
new cancer
new
treatments
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16696/00A
Inventor
Angus George Dalgleish
Peter Michael Smith
Andrew Derek Sutton
Anthony Ian Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Onyvax Ltd
Original Assignee
Onyvax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyvax Ltd filed Critical Onyvax Ltd
Publication of AU1669600A publication Critical patent/AU1669600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • A61K2039/884Vaccine for a specifically defined cancer prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU16696/00A 1998-12-10 1999-12-09 New cancer treatments Abandoned AU1669600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9827102.6A GB9827102D0 (en) 1998-12-10 1998-12-10 New cancer treatments
GB9827102 1998-12-10
PCT/GB1999/004146 WO2000033871A2 (en) 1998-12-10 1999-12-09 Use of human prostate tumour cell lines in cancer treatment

Publications (1)

Publication Number Publication Date
AU1669600A true AU1669600A (en) 2000-06-26

Family

ID=10843924

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16696/00A Abandoned AU1669600A (en) 1998-12-10 1999-12-09 New cancer treatments

Country Status (3)

Country Link
AU (1) AU1669600A (en)
GB (1) GB9827102D0 (en)
WO (1) WO2000033871A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176022B2 (en) 2002-12-20 2007-02-13 Cell Genesys, Inc. Directly injectable formulations which provide enhanced cryoprotection of cell products
US20050019336A1 (en) * 2003-07-23 2005-01-27 Dalgleish Angus George Human prostate cell lines in cancer treatment
US20050180952A1 (en) * 2003-08-26 2005-08-18 Pettis Ronald J. Methods for intradermal delivery of therapeutics agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982168B1 (en) * 1996-02-02 2006-01-03 The United States Of America As Represented By The Department Of Health And Human Services Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer

Also Published As

Publication number Publication date
WO2000033871A3 (en) 2000-10-12
WO2000033871A2 (en) 2000-06-15
GB9827102D0 (en) 1999-02-03

Similar Documents

Publication Publication Date Title
AU4525799A (en) Requirements matching
HUP0104857A3 (en) New cancer treatments
AU2882299A (en) Anti-asthma therapy
AU5970699A (en) Use
AU1772399A (en) Well treatment
AU2025199A (en) Collider
GB9805877D0 (en) Cancer
AU1710600A (en) Enhanced radiation therapy
AU2001257325A1 (en) Cancer treatment
AUPP584198A0 (en) New use
AU5998199A (en) New bis-benzimidazoles
AU1669600A (en) New cancer treatments
GB9804361D0 (en) Cancer treatment
AU6235799A (en) New use
AU2453399A (en) Bone cancer therapy
AU4089699A (en) Tumor suppressor
AU4598100A (en) Treating cancer
AU5524399A (en) Inorgasmia treatment
HK1033176A (en) Treating cancer
HK1033179A (en) Treating cancer
HK1033175A (en) Treating cancer
HK1033178A (en) Treating cancer
HK1033177A (en) Treating cancer
HK1033173A (en) Treating cancer
HK1033174A (en) Treating cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase